Pretreatment P53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with bacillus calmette-guerin (BCG)

By Saint F.   Le Frere Belda M.A.   Quitela R.   Gil Diez De Medina S.   Hoznek A.   Patard J.J.   Bellot J.   Popov Z.   Zafrani E.S.   Abbou C.C.   Chopin D.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 86-86

Elsevier

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guerin Treatment Improves Patient Survival in T1G3 Bladder Tumours

By Patard J.-J.   Rodriguez A.   Leray E.   Rioux-Leclercq N.   Guille F.   Lobel B.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 635-642

Elsevier

Access to resources Recommend Favorite

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K.   Schultz M.   Stout P.   Fan K.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience

By Pansadoro V.   Emiliozzi P.   de Paula F.   Scarpone P.   Pansadoro A.   Sternberg C.N.  

Urology, Vol. 59, Iss. 2, 2002-02 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

Long-term results of intravesical bacillus calmette-guerin therapy for stage T1 superficial bladder cancer

By Brake M.   Loertzer H.   Horsch R.   Keller H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 673-678

Elsevier

Access to resources Recommend Favorite